R. Michael Alvarez

Suggest Changes
Learn More
BACKGROUND OnabotulinumtoxinA (onabotA) has shown its efficacy over placebo in chronic migraine (CM), but clinical trials lasted only up to one year. OBJECTIVE The objective of this article is to(More)